Drug-induced long QT syndrome: a continuing challenge in the field

J Cardiovasc Electrophysiol. 2007 Jul;18(7):696-7. doi: 10.1111/j.1540-8167.2007.00866.x. Epub 2007 May 30.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Anti-Arrhythmia Agents / adverse effects
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels / antagonists & inhibitors
  • Ether-A-Go-Go Potassium Channels / genetics
  • Humans
  • Long QT Syndrome / chemically induced*
  • Long QT Syndrome / genetics
  • Long QT Syndrome / physiopathology*
  • Mutation
  • Potassium Channel Blockers / adverse effects

Substances

  • Anti-Arrhythmia Agents
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Potassium Channel Blockers